Pricing Log in Create free account

Kailera Therapeutics, Inc. (KLRA) vs Sarepta Therapeutics, Inc. (SRPT)

Kailera Therapeutics, Inc. and Sarepta Therapeutics, Inc. are both Biotechnology companies. Kailera Therapeutics, Inc. and Sarepta Therapeutics, Inc. are of similar size ($1.7B and $1.7B). Kailera Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Sarepta Therapeutics, Inc. trades at 182×. Sarepta Therapeutics, Inc. has the higher net margin (0.75% vs 0.00%) and the higher return on invested capital (−2.26% vs −182.9%). Across the 12 metrics below, Sarepta Therapeutics, Inc. leads on 8 and Kailera Therapeutics, Inc. on 4.

Valuation

Metric KLRA SRPT Biotechnology median
P/E n/m 182.33 11.36
P/S n/m 0.87 9.12
P/B 1.67 1.12 2.14
Price to free cash flow n/m 9.91 26.34
EV/EBITDA n/m n/m 0.62
EV/Sales n/m 0.83 8.56
Earnings yield 643,613,520.09% 0.55% (34.18%)
Free cash flow yield (18.88%) 10.09% (23.62%)

Profitability

Metric KLRA SRPT Biotechnology median
Gross margin — 56.79% 67.24%
Operating margin 0.00% (2.50%) 0.00%
Net margin 0.00% 0.75% 0.00%
Free cash flow margin 0.00% 8.79% 0.00%
Return on equity (85.74%) 1.04% (50.28%)
Return on assets (55.25%) 0.44% (45.89%)
Return on invested capital (182.92%) (2.26%) 0.00%

Growth

Metric KLRA SRPT Biotechnology median
Revenue growth (TTM) — (18.95%) 6.96%
EPS growth (last fiscal year) — (404.70%) 29.86%
Revenue growth, 5-year CAGR — 32.41% 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric KLRA SRPT Biotechnology median
Debt to equity 0.00 0.46 0.00
Current ratio 21.84 3.46 4.72
Net debt to EBITDA 3.46 0.17 1.01

Dividend

Metric KLRA SRPT Biotechnology median
Dividend yield — — 0.39%
Payout ratio — — —

Size

Metric KLRA SRPT Biotechnology median
Market cap 1.72b 1.72b 167.45m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack